Is Pasupati Fincap overvalued or undervalued?
As of August 19, 2025, Pasupati Fincap's valuation has shifted to risky due to severe financial distress, reflected in its negative PE ratio of -10.83 and a year-to-date return of -43.71%, contrasting sharply with its peers like Life Insurance, which has a PE ratio of 11.61.
As of 19 August 2025, the valuation grade for Pasupati Fincap has moved from very attractive to risky, indicating a significant deterioration in its financial outlook. The company is currently deemed overvalued given its negative PE ratio of -10.83, a price to book value of -10.83, and an EV to EBITDA of -10.83, all of which highlight severe financial distress. In comparison to its peers, Pasupati Fincap's metrics starkly contrast with Life Insurance, which has a PE ratio of 11.61 and an EV to EBITDA of 9.04, both classified as very attractive. Other competitors like Bajaj Finance and Bajaj Finserv exhibit much higher valuations, with PE ratios of 32.19 and 33.08, respectively, categorizing them as very expensive. The recent stock performance shows a stark decline, with a year-to-date return of -43.71%, while the Sensex has gained 4.49% in the same period, further reinforcing the notion that Pasupati Fincap is overvalued in its current state.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
